Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Response and Outcome in Non-small Cell Lung Cancer Patients With Brain Metastasis

NCT05737589 is registered in ClinicalTrials.gov with Xiaorong Dong as lead sponsor.

NCT NCT05737589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05737589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Response and Outcome in Non-small Cell Lung Cancer Patients With Brain Metastasis
Lead sponsor
Xiaorong Dong
Phase
Observational
Overall status
Unknown status
Start date
February 13, 2023
Completion date
October 1, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, carcinoma, non-small-cell lung